Affiliations
AffiliationItem in Clipboard
Deaths preventable in the U.S. by improvements in use of clinical preventive servicesThomas A Farley et al. Am J Prev Med. 2010 Jun.
doi: 10.1016/j.amepre.2010.02.016. AffiliationItem in Clipboard
AbstractBackground: Healthcare reform plans refer to improved quality, but there is little quantification of potential health benefits of quality care.
Purpose: This paper aims to estimate the health benefits by greater use of clinical preventive services.
Methods: Two mathematical models were developed to estimate the number of deaths potentially prevented per year by increasing use of nine clinical preventive services. One model estimated preventable deaths from all causes, and the other estimated preventable deaths from specific categories of causes. Models were based on estimates of the prevalence of risk factors for which interventions are recommended, the effect of those risk factors on mortality, the effect of the interventions on mortality in those at risk, and current and achievable rates of utilization of the interventions.
Results: Both models predicted substantial numbers of deaths prevented by greater use of the preventive services, with the greatest increases from services that prevent cardiovascular disease. For example, the all-cause model predicted that every 10% increase in hypertension treatment would lead to an additional 14,000 deaths prevented and every 10% increase in treatment of elevated low-density lipoprotein cholesterol or aspirin prophylaxis would lead to 8000 deaths prevented in those aged <80 years, per year. Overall, the models suggest that optimal use of all of these interventions could prevent 50,000-100,000 deaths per year in those aged <80 years and 25,000-40,000 deaths per year in those aged <65 years.
Conclusions: Substantial improvements in population health are achievable through greater use of a small number of preventive services. Healthcare systems should maximize use of these services.
2010 American Journal of Preventive Medicine. All rights reserved.
Similar articlesManton KG. Manton KG. World Health Stat Q. 1988;41(3-4):255-66. World Health Stat Q. 1988. PMID: 3232413
Biggeri A, Bellini P, Terracini B; Italian MISA Group. Biggeri A, et al. Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71. Epidemiol Prev. 2001. PMID: 11515188 Italian.
Morimoto T, Fukui T, Lee TH, Matsui K. Morimoto T, et al. Am J Med. 2004 Oct 1;117(7):459-68. doi: 10.1016/j.amjmed.2004.04.017. Am J Med. 2004. PMID: 15464702 Review.
Berg CJ, Harper MA, Atkinson SM, Bell EA, Brown HL, Hage ML, Mitra AG, Moise KJ Jr, Callaghan WM. Berg CJ, et al. Obstet Gynecol. 2005 Dec;106(6):1228-34. doi: 10.1097/01.AOG.0000187894.71913.e8. Obstet Gynecol. 2005. PMID: 16319245 Review.
Gollamudi SS, Topol EJ, Wineinger NE. Gollamudi SS, et al. PeerJ. 2016 Aug 2;4:e2284. doi: 10.7717/peerj.2284. eCollection 2016. PeerJ. 2016. PMID: 27547580 Free PMC article.
Cohen DJ, Balasubramanian BA, Gordon L, Marino M, Ono S, Solberg LI, Crabtree BF, Stange KC, Davis M, Miller WL, Damschroder LJ, McConnell KJ, Creswell J. Cohen DJ, et al. Implement Sci. 2016 Jun 29;11(1):86. doi: 10.1186/s13012-016-0449-8. Implement Sci. 2016. PMID: 27358078 Free PMC article.
Angell S, Guthartz S, Dalal M, Foster V, Pogue V, Wei A, Chamany S, Yi S. Angell S, et al. J Clin Hypertens (Greenwich). 2013 Mar;15(3):180-5. doi: 10.1111/jch.12046. Epub 2013 Jan 22. J Clin Hypertens (Greenwich). 2013. PMID: 23458590 Free PMC article.
Bogner HR, de Vries HF, Kaye EM, Morales KH. Bogner HR, et al. Fam Med. 2013 May;45(5):323-9. Fam Med. 2013. PMID: 23681683 Free PMC article. Clinical Trial.
National Vaccine Advisory Committee. National Vaccine Advisory Committee. Public Health Rep. 2012 Jan-Feb;127 Suppl 1(Suppl 1):1-42. doi: 10.1177/00333549121270s101. Public Health Rep. 2012. PMID: 22210957 Free PMC article. No abstract available.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3